The Effects of Sodium Fluoride and Chlorhexidine Use on Salivary IL-6 and Matrix Metalloproteinase Levels in Children With Active Caries

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-8
SponsorGül Keskin

About this trial

This study aims to compare salivary IL-6, MMP-8, MMP-9, and TIMP-1 levels between healthy children and caries-active children, and to evaluate the effects of 5% sodium fluoride (NaF) varnish and 2% chlorhexidine (CHX) used in caries prevention on these biomarkers.

The study will be conducted at Alanya Alaaddin Keykubat University, Faculty of Dentistry, Department of Pediatric Dentistry. Informed consent will be obtained from children and their parents/guardians. Investigator calibration will be performed using Cohen's kappa method prior to data collection. Sample size was calculated assuming 80% power (1-β = 0.80), α = 0.05, and Cohen's d ≈ 0.8, resulting in 20 participants per group using G\*Power 3.1 software.

Study groups: Group A: 5% NaF varnish. Group B: 2% CHX + 5% NaF varnish. Group C: Standard oral hygiene education (negative control). Group D: Caries-free children (biological reference; baseline saliva sampling only).

Saliva samples will be collected at T0 (baseline), T1 (30 minutes post-application), and T2 (1 month). Unstimulated whole saliva will be collected, centrifuged at 5,000 g for 10 minutes at 4°C, and stored at -80°C. IL-6, MMP-8, MMP-9, and TIMP-1 levels will be measured using CE-marked/FDA-approved human saliva ELISA kits.

Eligibility criteria

Qualifiers

Children aged 6-8 years with all first permanent molars erupted

For active caries groups (Groups A, B, C): participants must meet at least one of the following criteria: dmft ≥ 6, or presence of at least one active caries lesion with an ICDAS code ≥ 3, or clinical evidence of active caries on ≥ 10 surfaces

For the dmft = 0 reference group (Group D): all surfaces caries-free and non-high-risk individuals (ICDAS II = 0); only baseline (T0) saliva sampling will be performed

No professional topical fluoride application or continuous CHX use within the past 3 months

Disqualifiers

Known allergy to fluoride compounds or varnish components

Behavioral problems that would prevent safe cooperation during application

Regular antibiotic use within the past 1 month

Individuals with infectious diseases

Trial design

Treatments tested in this trial

  • 5% Sodium Fluoride Varnish
  • 2% Chlorhexidine Pre-Treatment + 5% NaF Varnish
  • Standard Oral Hygiene Education

Treatment groups

80 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Gül Keskin

Lead sponsor

Alanya Alaaddin Keykubat University

Sponsor institution

Alanya Alaaddin Keykubat University

Collaborator